Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes
- PMID: 3115596
- DOI: 10.1016/0008-8749(87)90296-6
Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes
Abstract
The effects of cyclosporin A (CyA) on the activation processes of cloned murine cytotoxic T lymphocytes (CTL) have been examined. With the use of Day 7 resting cloned CTL it was possible to separate the functions of lymphokine production (macrophage-activating factor, MAF) and interleukin 2 (IL-2)-induced proliferation of these cells. The effect of CyA on each of these activities was analyzed independently. CyA was found to inhibit both receptor-mediated MAF production in response to stimulation with antigen and lectin and MAF production in response to non-receptor-mediated stimulation (by anti-Thy-1 antibodies, ionophore, and phorbol ester). Further, CyA was observed to inhibit the re-entry of these resting CTL into the cell cycle upon stimulation with IL-2. The effect of CyA on MAF production did not appear to be due to inhibition of the signal-transducing mechanism involved in this process (i.e., inositol lipid hydrolysis, calcium mobilization, and protein phosphorylation). The action of CyA on the IL-2-induced proliferation was not due to inhibition of IL-2 receptor expression or the binding of IL-2 to its receptor. Thus, CyA appeared to mediate its suppressive effects on MAF production and IL-2-induced proliferation through an action on some later step(s) in the signal pathways of these activities.
Similar articles
-
Molecular mechanisms involved in T cell activation. III. The role of extracellular calcium in antigen-induced lymphokine production and interleukin 2-induced proliferation of cloned cytotoxic T lymphocytes.J Immunol. 1988 Feb 1;140(3):921-7. J Immunol. 1988. PMID: 3276784
-
Molecular mechanisms involved in T cell activation. I. Evidence for independent signal-transducing pathways in lymphokine production vs proliferation in cloned cytotoxic T lymphocytes.J Immunol. 1987 Jan 15;138(2):600-5. J Immunol. 1987. PMID: 3540123
-
Molecular mechanisms involved in T cell activation. II. The phosphatidylinositol signal-transducing mechanism mediates antigen-induced lymphokine production but not interleukin 2-induced proliferation in cloned cytotoxic T lymphocytes.J Immunol. 1987 Jan 15;138(2):606-12. J Immunol. 1987. PMID: 3540124
-
Direct and indirect modes of action of cyclosporine on cytotoxic T lymphocytes.Ann N Y Acad Sci. 1988;532:405-12. doi: 10.1111/j.1749-6632.1988.tb36358.x. Ann N Y Acad Sci. 1988. PMID: 3052214 Review. No abstract available.
-
Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor.Immunol Res. 1988;7(2):113-35. doi: 10.1007/BF02918096. Immunol Res. 1988. PMID: 3134498 Review.
Cited by
-
Cyclosporin for Crohn's disease?Drugs. 1992 Apr;43(4):440-2. doi: 10.2165/00003495-199243040-00002. Drugs. 1992. PMID: 1377112 Review. No abstract available.
-
Cyclosporin A for primary biliary cirrhosis.Cochrane Database Syst Rev. 2007 Jul 18;2007(3):CD005526. doi: 10.1002/14651858.CD005526.pub2. Cochrane Database Syst Rev. 2007. PMID: 17636804 Free PMC article.
-
Cyclosporin A prevents the in vivo development of murine prothymocytes from uncommitted (Thy-1-) precursor cells.Immunology. 1989 Dec;68(4):564-9. Immunology. 1989. PMID: 2575078 Free PMC article.
-
Cyclosporin A treatment in inflammatory bowel disease.Dig Dis Sci. 1989 Sep;34(9):1387-92. doi: 10.1007/BF01538074. Dig Dis Sci. 1989. PMID: 2766906
-
In vitro and in vivo action of cyclosporin A on the induction of human interleukin-2 receptor alpha and beta chains.Clin Exp Immunol. 1989 Aug;77(2):184-90. Clin Exp Immunol. 1989. PMID: 2789115 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources